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Abstract
Background: The prevalence of dietary supplements has increased in Japan, and, as a consequence, the adverse
events associated with dietary supplement use have become more prominent. Severe adverse events must be
reported to the Japanese government via public health centers. However, the number of cases reported to the
Japanese government is limited. To clarify this discrepancy, we conducted an internet questionnaire, and surveyed
how consumers, physicians and pharmacists acted when they or their patients developed adverse events due to
dietary supplement use.
Methods: This study was completed by 2732 consumers, 515 physicians, and 515 pharmacist via internet
surveillance on November 2015.
Results: Although 8.8% of consumers developed adverse events including diarrhea, constipation, stomachache,
headache, and nausea and vomiting, most of them did not report their adverse events to public health centers.
However, some consumers went to hospitals because of adverse events. We also surveyed how physicians and
pharmacists acted when their patients developed adverse events due to dietary supplement use. Most physicians
and pharmacists did not report these cases to public health centers because they were unable to definitively prove
the cause-and-effect relationship of these adverse events. Furthermore, some physicians and pharmacists did not
know how or where to report these adverse events.
Conclusions: We clarified the reasons for the limited number of reports of adverse events to the Japanese
government in this survey. It is important to encourage not only consumers, but also physicians and pharmacists to
report adverse events to public health centers. In addition, an analyzing tool of cause-and-effect relationships might
be helpful for physicians and pharmacists.
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Background
The prevalence of dietary supplements, which are help-
ful to supply nutrients for health, has increased in Japan
[1–3]. Consumers use not only vitamins and minerals,
but also various other ingredients as dietary supple-
ments. However, most consumers do not understand the
properties of dietary supplements and their ingredients,
which may be beneficial, but are also associated with a
risk of adverse reactions, such as gastrointestinal and
neurological complications, hepatotoxicity, and interac-
tions with drugs [4–8]. The reasons for misunderstand-
ing of consumers are that manufacturers tend to
emphasize the key characteristics of their products and
promote sales using attractive claims [9]. Furthermore,
some dietary supplements have claimed beneficial effects
for the treatment of several diseases, even though these
claims are illegal in Japan. Under these conditions,
consumers use dietary supplements inappropriately,
thereby increasing the risk of adverse events.
There are several causes of adverse events due to dietary
supplement use, the first of which is the use of low quality
dietary supplements. For example, an excess amount of
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heavy metals or unlabeled ingredients associated with al-
lergies may contaminate products. Drug ingredients, such
as sibutramine, sildenafil, and dexamethasone, are added
to dietary supplements [10, 11]. A large number of studies
have reported a relationship between adverse events and
the use of these products. Another cause of adverse events
is consumer characteristics. Some individuals develop
allergic reactions to the ingredients of dietary supple-
ments. Infants/children, pregnant and lactating women,
and the elderly are influenced more by dietary supple-
ments [12, 13]. In addition, patients, particularly those
receiving medication, need to be more cautious of
dietary supplement use [14]. A third cause of adverse
events is the inappropriate use of dietary supplements
including an excessive intake or the concomitant use
of various dietary supplements and/or medicines. In
the past few decades, a large number of ingredients
have been shown to interact with drugs [15–21]; how-
ever, it currently remains unclear whether most ingre-
dients in dietary supplements interact with drugs.
We previously reported that some dietary supplement
users in Japan experienced adverse events [22, 23]. There
are several ways by which to report the adverse events
associated with dietary supplement use in Japan.
Consumers report their adverse events to manufacturers
or retail stores. In the US, dietary supplements are regu-
lated by the Dietary Supplement Health and Education
Act (DSHEA) [24, 25]. Under the DSHEA, the manufac-
turers, packers, and distributors of dietary supplements
are required to submit the main associated adverse
events to the US Food and Drug Administration (FDA)’s
Center for Food Safety and Applied Nutrition Adverse
Event Reporting System (CAERS) within 15 business
days of receiving information on adverse events. On the
other hand, manufacturers do not have a duty to report
adverse events to the Ministry of Health, Labour and
Welfare (MHLW) in Japan, which regulates adverse
events associated with dietary supplement use.
Therefore, the majority of complaints are handled by
each manufacturer. Consumers also have the option of
reporting adverse events to the Practical Living
Information Online Network System (PIO-NET), which
is the operating system of the National Consumer
Affairs Center of Japan. Several hundred cases per year
are reported to the PIO-NET [26]. However, most
reports cannot define cause-and-effect relationships
because the information obtained from consumers is not
considered to be sufficient to define these relationships.
Furthermore, consumers themselves or their physicians
or pharmacists report severe adverse events associated
with dietary supplement use to public health centers,
which then report adverse events to the MHLW. How-
ever, only 20 adverse events per year are reported to the
MHLW. Therefore, the Japanese government cannot
take action against adverse events associated with diet-
ary supplement use. The cause of the limited number
of adverse events reported to the MHLW currently
remains unclear.
In the present study, we surveyed how consumers
behaved when they experienced adverse events associ-
ated with dietary supplement use. We also surveyed how
physicians and pharmacists advised their patients and
whether they reported adverse events to public health
centers.
Methods
Definition of “dietary supplement”
In Japan, “dietary supplement” has no definition in the
law, and some dairy or soybean products are recognized
as dietary supplements even if they are in the form of
common foods. Therefore, the meaning of the term “diet-
ary supplement” differs for each individual. In this survey,
“dietary supplement” was defined as those that consumers
considered to have beneficial effects on their health (e.g.,
vitamins, minerals, fish oil, glucosamine, cereal) except for
daily foods (e.g., vegetables, fruits, milk, tofu).
Internet survey
An internet-based questionnaire was conducted by
Macromill, Inc. (Tokyo, Japan) with their research regis-
trants (2 million registrants in 2015) between 13
November and 19 November 2015 on consumers, and
between 13 November and 18 November 2015 on
physicians and pharmacists. This study was conducted
with the approval of the Research Ethics Committee of
the National Institutes of Biomedical Innovation, Health
and Nutrition (No.198-1, approved on Aug. 28, 2015)
and in accordance with Declaration of Helsinki.
Preliminary survey for subjects who experienced adverse
effects due to dietary supplement use
To extract consumers who experienced adverse events
due to dietary supplement use, a preliminary survey was
conducted with randomly selected 70,000 consumers
from research registrants of Macromill, Inc. (Additional
file 1). Of these, 24,295 subjects (34.7%) were currently
using dietary supplements, 18,194 (26.0%) had used diet-
ary supplements in the past, and 27,511 (39.3%) have
never used dietary supplements. We asked current- and
ex-users of dietary supplements whether they had expe-
rienced adverse events (diarrhea, constipation, stomach-
ache, headache, nausea and vomiting, fatigue, anthema
and itching, palpitations, worsening health examination
data, or other symptoms) due to dietary supplement use.
A total of 6129 subjects (8.8%) experienced adverse
events, and a part of these consumers answered the full
survey. Veterinary surgeons and dentists were excluded
from the survey because they had few opportunities to
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be asked by patients about the adverse events associated
with dietary supplement use.
Full survey
The full survey was conducted on 3095 consumers who
experienced adverse events (Additional file 2). The ques-
tionnaire included the purpose of supplementation
(maintenance of health, improvements to health, for
beauty or weight loss, prevention of diseases, and treat-
ment of diseases), types of dietary supplements, their re-
sponses to adverse events which associated by dietary
supplement use, and their reasons if they did not report
it to public institutes. Among physicians and pharma-
cists, the survey was conducted on 1030 subjects (515
physicians and 515 pharmacists) (Additional file 3). The
questionnaire included their experiences of being asked
by patients about adverse events associated with dietary
supplement use, what advice they gave their patients,
whether they reported it to public institutes, and their
reasons if they did not report it to public institutes. The
demographic characteristics (sex and age) were obtained
from the research registrants’ data of Macromill, Inc.
Statistical analysis
Differences among groups were tested using the χ2 test.
Statistical analyses were performed using HALBAU 7.5.1
(HALBAU R&D Co., Ltd., Tokyo). P-values less than
0.05 were considered significant.
Results
Characteristics
Characteristics of consumers, physicians and pharma-
cists are shown in Table 1. Consumers (n = 3095) were
as follows: sex (male; 1340, female; 1755), age (20s; 468,
30s; 736, 40s; 634, 50s; 611, older than 60; 646). The
characteristics of physicians and pharmacists (n = 1030)
were as follows: sex (female; 379, male; 651), age (20s;
64, 30s; 248, 40s; 317, 50s; 289, older than 60; 112). Phy-
sicians (515) specialized in internal medicine; 214,
pediatrics; 34, obstetrics and gynecology; 18, and others;
249. Pharmacists (515) worked in dispensing pharma-
cies; 416, drugstores; 24, and others; 75.
Purpose of dietary supplement use
The purposes indicated by consumers for the use of
dietary supplements are shown in Table 2. The main rea-
son that consumers used dietary supplement was for the
maintenance of health. Other reasons were for improve-
ments to health, for beauty, the prevention of diseases,
weight loss, and the treatment of disease. The prevalence
of the prevention of disease, weight loss, and treatment
of disease was significantly higher in subjects who expe-
rienced adverse events in the full survey than in all sub-
jects in the preliminary survey. This result suggests that
dietary supplements for these purposes cause more ad-
verse events.
In addition, ratio of who used dietary supplement to
treat their diseases was greater in subject who experi-
enced adverse events (7.2%) compared to all subject
(4.0%). This data suggests that adverse events were more
frequently occurred, when they used dietary supple-
ments to treat their diseases.
Symptoms of adverse events
The symptoms of adverse events due to dietary supple-
ment use are shown in Table 3. Diarrhea was the most
frequent adverse event, followed by nausea and vomit-
ing, fatigue, and constipation. Diarrhea, nausea and
vomiting, headache, and stomachache were significantly
more prevalent in younger consumers than in the
elderly. On the other hand, anthema and itching and
worsening health examination data were significantly
more prominent in the elderly than in younger
consumers.Table 1 Characteristics of consumers, physicians and
pharmacists
Consumers Physicians Pharmacists
n % n % n %
All 3095 515 515
Sex
Male 1340 43.3 440 85.4 211 41.0
Female 1755 56.7 75 14.6 304 59.0
Age
20–29 468 15.1 10 1.9 54 10.5
30–39 736 23.8 71 13.8 177 34.4
40–49 634 20.5 171 33.2 146 28.3
50–59 611 19.7 192 37.3 97 18.8
≥ 60 646 20.9 71 13.8 41 8.0
Table 2 Purpose of dietary supplement use
AEa Allb
n % n %
Maintenance of health 2336 75.5 33,347 78.5
Improvements to health 936 30.2 9500 22.4
For beauty 841 27.2 9977 23.5
Prevention of diseases 742 24.0 7906 18.6
Weight loss 738 23.8 7014 16.5
Treatment of diseases 222 7.2 1714 4.0
Others 63 2.0 821 1.9
asubjects who experienced adverse events (n = 3095)
ball subjects who were using or used to use dietary supplement in preliminary
survey (n = 42,489)
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Details of dietary supplements potentially associated with
adverse events
Details of dietary supplements potentially associated
with adverse events are shown in Table 4. Among vita-
mins/minerals, multi-vitamins were more frequently as-
sociated with adverse events than multi-minerals or
multi-vitamins and minerals. Individual mineral, such as
Fe, Zn, and Ca, and individual vitamin, including vitamin
B, vitamin C, and vitamin E also caused adverse events.
Furthermore, various non-vitamin, non-mineral supple-
ments were associated with the development of adverse
events. Coleus forskohlii, which is one of the popular in-
gredients used to promote weight loss in Japan, was the
top ingredient that caused adverse events at a rate that
was more than two-fold that of glucosamine/chondro-
itin, garlic, sesamin, collagen, and other ingredients. In
addition, weight loss supplements (except for Coleus for-
skohlii) were strongly associated with the development
of adverse events.
Responses of consumers to adverse events
Responses of consumers to adverse events are shown in
Table 5. Almost half of consumers stopped using dietary
supplements immediately. Adverse events are typically
ameliorated by the discontinuation of dietary supple-
ments. On the other hand, one-third of consumers did
nothing. Only 5.8% of consumers reported adverse
events to public institutes (5.1% to public health centers,
0.5% to the National Consumer Affairs Center of Japan
or other consumer affairs centers, and 0.2% to the
MHLW or Consumer Affairs Agency, Government of
Japan). The reason why most consumers did not report
to public institutes was “adverse events were not suffi-
ciently severe to make a complaint (70.8%)”. Other rea-
sons were “there were other possibilities for adverse
Table 3 Adverse events due to dietary supplement use (n = 3095)
All (%) 20s (%) 30s (%) 40s (%) 50s (%) Older than 60 (%) P-value
Diarrhea 27.9 35.0 32.7 29.3 27.3 16.4 <0.001
Nausea & vomiting 19.1 23.7 22.8 21.3 17.3 11.0 <0.001
Fatigue 17.4 19.7 17.4 18.6 15.4 16.3 0.327
Constipation 17.0 17.7 16.4 15.6 15.5 20.0 0.189
Headache 15.6 22.4 19.0 15.9 13.7 8.4 <0.001
Stomachache 15.4 23.1 17.7 15.1 13.3 9.4 <0.001
Anthema & itching 15.0 11.8 13.0 14.8 14.1 20.6 <0.001
Worsening data of health examination 10.2 4.3 4.1 8.2 11.9 22.0 <0.001
Palpitations 5.5 4.5 5.7 5.7 5.6 5.7 0.895
Others 11.6 9.6 9.4 11.0 13.1 14.9 0.009
Statistical analysis were conducted among ages in each event. P-values were calculated using the χ2 test






Multi-vitamins and minerals 15 0.5
Individual vitamin (vitamin B, vitamin C, and vitamin E) 162 5.2
Individual mineral (Fe, Zn, and Ca) 214 6.9
Non-Vitamin, Non-Mineral (Top 10)






EPA/DHA/Fish oil/n-3 PUFA 50 1.6
Placenta 44 1.4
Enzymes 42 1.4
Royal jelly/Propolis 41 1.3
Weight loss supplements (except for Coleus forskohlii) 155 5.0
Table 5 Responses of consumers to adverse events
n Percent
Stopped using dietary supplements immediately 1669 53.9
Did nothing 1164 37.6
Went to a hospital 184 5.9
Complained to manufacturers 167 5.4
Reported to public health centers 159 5.1
Complained to the retail store 42 1.4
Reported to the National Consumer Affairs Center of
Japan or other consumer affairs centers
16 0.5
Reported to the MHLW or Consumer Affairs Agency,
Government of Japan
6 0.2
MHLW Ministry of Health, Labour and Welfare
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events (28.1%)” or “making a complaint to public
institutes was considered to be too troublesome (13.5%)”.
A total of 5.9% of consumers who experienced adverse
effects went to a hospital. Physicians and pharmacists
have a responsibility to report adverse events associated
with dietary supplement use to public health centers.
Consultations regarding adverse events
We conducted a survey on physicians and pharmacists re-
garding consultations related to dietary supplements. The
57.3% (295/515) of physicians and 59.0% (304/515) of
pharmacists were asked about dietary supplement use by
their patients. Of these, 25.4% (131/515) of physicians and
19.6% (101/515) of pharmacists had consultations on
adverse events with their patients (Table 6). Physicians
had significantly more opportunities for consultations on
adverse events as compared to pharmacists. Most
consultations only occurred 1–2 times, whereas some
were more than 3 times. A total of 11.5% (15/131) of
physicians and 6.9% (7/101) of pharmacists had more than
10 consultations.
Responses of physicians and pharmacists to adverse
events among their patients
Among physicians and pharmacists who had consultations
on adverse events, most physicians (84.0%) and pharma-
cists (75.2%) advised their patients to stop using dietary
supplements immediately (Table 7). On the other hand,
only 12.3% of physicians and 17.5% pharmacists reported
these events to public institutes (8.4 and 11.9% to public
health centers, 3.1 and 5.9% to the National Consumer
Affairs Center of Japan or other consumer affairs centers,
and 0.8 and 1.0% to the Consumer Affairs Agency,
Government of Japan). There were no significant
differences in behaviors between physicians and pharma-
cists, except for ask manufactures. Pharmacists (18.8%)
significantly more frequently asked manufactures about
their products compared to Physicians (3.8%).
Reasons why physicians and pharmacists did not report
adverse events to public health centers
The reasons why physicians and pharmacists did not re-
port adverse events to public health centers were similar
(Table 8). They were unable to define case-and-effect
relationships for adverse events. Furthermore, they did
not know what level of severity needed to be reported.
These two reasons were significantly higher in pharma-
cists than physicians. On the other hand, one third of
physicians and pharmacists did not know to where to
report adverse events. This reason was significantly
higher in physicians than pharmacists.
Discussion
We previously reported that some patients used dietary
supplements to treat their diseases [22], and concomi-
tantly used dietary supplements and medicines [23]. The
inappropriate usage of dietary supplements causes adverse
events. The percentages of consumers who experienced
Table 6 Opportunity of consultations related to adverse
reactions with their patients
Physicians Pharmacists
n % n % P-value
Yes, I have. 131 25.4 101 19.6 0.030
No, I have never. 384 74.6 414 80.4
Number of times
1–2 75 14.6 69 13.4 0.081
3–5 38 7.4 19 3.7
6–9 3 0.6 6 1.2
More than 10 15 2.9 7 1.4
Physicians (n = 515), Pharmacists (n = 515), P-values were calculated using the
χ2 test
Table 7 Responses of physicians and pharmacists to adverse
events among their patients
Physicians Pharmacists
n % n % P-value
Advice to stop using dietary
supplements immediately
110 84.0 76 75.2 0.137
Nothing apart from a follow-up 32 24.4 24 23.8 1.000
Ask patients to report to other
institutes by themselves
14 10.7 19 18.8 0.117
Ask manufacturers about their
products
5 3.8 19 18.8 <0.001
Report to public health centers 11 8.4 12 11.9 0.510
Report to the National Consumer
Affairs Center of Japan or other
consumer affairs centers
4 3.1 6 5.9 0.455
Report to the Consumer Affairs
Agency, Government of Japan
1 0.8 1 1.0 -
Others 4 3.1 3 2.3 -
Physicians (n = 131), Pharmacists (n = 101), P-values were calculated using the
χ2 test
Table 8 Reasons why physicians and pharmacists did not
report adverse events to public health centers
Physicians Pharmacists
n % n % P-value
It is difficult to define a cause-and-
effect relationship
284 55.1 343 66.6 <0.001
It is not clear which case (severity)
needs to be reported
214 41.6 249 48.3 0.033
It is not clear where to report 224 43.5 172 33.4 0.001
Cumbersome procedure to report 61 11.8 51 9.9 0.368
Others 18 3.5 11 2.1 0.258
Physicians (n = 515), Pharmacists (n = 515), P-values were calculated using the
χ2 test
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adverse events were 3.3 and 8.4% in each report. Several
hundred complaints about adverse events due to dietary
supplement use are reported to the National Consumer
Affairs Center of Japan or other consumer affairs centers
every year [26]. However, our results showed that most
consumers, physicians, and pharmacists did not report
adverse events to public health centers. This is the main
reason why the number of adverse events reported to the
MHLW is limited.
In the US, dietary supplements are regulated by the
DSHEA; however, the DSHEA does not work well. The
FDA almost daily warns or recalls tainted dietary supple-
ments, such as the sexual enhancement products
containing sildenafil, tadalafil, or their analogues, the
weight-loss products containing sibutramine and the
laxative phenolphthalein, and the sports supplements
containing 1,3-dimethylamylamine or anabolic steroids.
On the other hand, manufacturers have to report
adverse events to the FDA’s CAERS [24, 25]. However,
inadequate and poor-quality reports on adverse events
associated with dietary supplements are the main limita-
tions of safety monitoring [4, 27]. This condition is simi-
lar to Japan. Although several hundred cases per year
are reported to the PIO-NET from consumers [26], most
reports are inadequate and of insufficient quality to
define cause-and-effect relationships. On the other hand,
the number of adverse event reports from physicians
and pharmacists is limited, but are based on clinical ex-
aminations. Therefore, it is important to increase the
number of adverse event reports from physicians and
pharmacists. However, some physicians and pharmacists
have inadequate knowledge about dietary supplements
and do not know how or where to report adverse events
[28, 29]. Furthermore, 28.0% of physicians and 35.1% of
pharmacists were using dietary supplements themselves,
while 20.6% of physicians and 35.1% of pharmacists had
previously used dietary supplements in this present
survey. This result indicates that half of physicians and
pharmacists might have a positive attitude towards diet-
ary supplements and may pay less attention to the
adverse events associated with their use.
There are some reports that most of patients did not
inform their physicians/pharmacists about dietary
supplement use, and communication between patients
and physicians/pharmacists was important to avoid ad-
verse events [22, 30]. On the other hand, there is no
report whether there are differences in attitude towards
dietary supplement use in their patients between
physicians and pharmacists, and whether physicians and
pharmacists discuss dietary supplement use in their
patients each other. In our survey, there were some
differences between physicians and pharmacists in op-
portunities for consultation, management of adverse
events, and their own personal supplement use. In this
regard, communication between physicians and pharma-
cists might be an important strategy to prevent adverse
events and to increase the number of adverse event re-
ports to public health centers.
Our survey also clarified the features of adverse events
among generations. This difference might be attributed
to the different types of dietary supplements used by
each generation. The prevalence of anthema and itching
was significantly higher among the elderly, who prefer to
use glucosamine/chondroitin for arthralgia [31]. Glu-
cosamine/chondroitin have been shown to induce an al-
lergic reaction [32]. On the other hand, the prevalence
of diarrhea was significantly higher in the younger gen-
eration, which prefers to use dietary supplements for
weight loss. In Japan, most young women want to lose
weight in order to maintain their appearance, even
though being excessively thin is an important issue
among this demographic [33]. A large number of dietary
supplements for weight loss contain Coleus forskohlii,
Red pepper, Senna, or other ingredients that may cause
diarrhea [34–36]. However, it is difficult to define cause-
and-effect relationships among them. A generation
difference has also been reported in adverse events in
the US [13]. Adverse events were associated with dietary
supplements for weight loss or energy products in youn-
ger generations, and with micronutrients in older gener-
ations. Therefore, appropriative information to avoid
adverse events are needed for each generation.
There are several limitations to the passive collection
of adverse reactions associated with dietary supplements.
Consumers, physicians, and pharmacists do not report
to public health centers if adverse events are not severe.
Furthermore, the numbers of reported adverse reactions
that define cause-and-effect relationships are very low.
Therefore, the MHLW cannot establish whether these
cases are common or singular. However, a one-year
prospective surveillance study on dietary supplement-
related poison control center calls enabled the rapid
detection of potentially harmful products [37]. In this
regard, the active collection of adverse events associated
with dietary supplements, such as an internet question-
naire, may be a useful method for the rapid detection of
harmful products because a large number of consumers
obtain information on dietary supplements via the
internet [38]. In addition, 23.5% of consumers con-
comitantly used dietary supplements and medicines in
this survey. There is a possibility that interaction of
dietary supplements and medicines might cause
adverse events. However, we could not estimate how
it contributed to our results, because we did not ask
in detail about their medications.
In this survey, we clarified that most of consumers did
not report adverse events by their self, and physicians
and pharmacists also did not report, because they could
Chiba et al. Nutrition Journal  (2017) 16:18 Page 6 of 8
not define cause-and-effect relationships. So, the number of
reports on adverse events to the MHLW are limited. There
are two possible ways by which to improve this limitation.
A large number of physicians and pharmacists are unable
to define case-and-effect relationships for adverse events. In
order to resolve this issue, easy-to-use assessment methods
(a modified Naranjo scale and modified FDA algorithm)
may be useful [39]. These methods enable cause-and-effect
relationships for adverse events to be determined. Further-
more, although some physicians and pharmacists reported
adverse events to public health centers, public health
centers may not report adverse events to the MHLW.
Public health centers may receive a large number of reports
that include several levels of adverse events. Public health
centers review these reports and only report severe adverse
events to the MHLW. Therefore, a survey on public health
centers is needed in order to clarify the extent to which
public health centers receive reports on adverse events and
what they report to the MHLW.
Conclusions
Our investigation revealed that a large number of con-
sumers experienced adverse events due to dietary supple-
ment use; however, most of these events were not severe.
Although some consumers went to a hospital because of
adverse events, physicians and pharmacists were unable to
define cause-and-effect relationships for adverse events.
Therefore, the reconsideration of a reporting system is
needed in order for the MHLW to collect reports on ad-
verse events. It is important that not only patients, but
also physicians and pharmacists actively report adverse
events to public health centers to decrease and prevent
adverse events due to dietary supplement use.
Additional files
Additional file 1: Preliminary Survey for Consumers. (DOCX 15 kb)
Additional file 2: Full Survey for Consumers. (DOCX 15 kb)
Additional file 3: Survey for Physicians and Pharmacists. (DOCX 15 kb)
Abbreviations
DHA: Docosahexaenoic acid; DSHEA: Dietary Supplement Health and
Education Act; EPA: Eicosapentaenoic acid; FDA: Food and Drug
Administration; MHLW: Ministry of Health, Labour and Welfare;




This work was supported by a grant from the Japanese Ministry of Health,
Labour and Welfare (No. 24220501).
Availability of data and materials
All data generated or analysed during this study are included in this
published article [and its supplementary information files].
Authors’ contributions
TC, HY, and KU conceived and designed the experiments; TC performed the
experiments; TC and YS analyzed the data; TC, EK, KI, and YS checked the data;
TC wrote the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was conducted with the approval of the Research Ethics
Committee of the National Institutes of Biomedical Innovation, Health and
Nutrition (No.198-1, approved on Aug. 28, 2015) and in accordance with
Declaration of Helsinki.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Information Center, National Institute of Health and Nutrition, National
Institutes of Biomedical Innovation, Health and Nutrition, 1-23-1 Toyama,
Shinjuku-ku, Tokyo 162-8636, Japan. 2Department of Drug Evaluation &
Informatics, Graduate School of Pharmaceutical Sciences, University of
Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
Received: 1 November 2016 Accepted: 7 March 2017
References
1. Hirayama F, Lee AH, Binns CW, Watanabe F, Ogawa T. Dietary
supplementation by older adults in Japan. Asia Pac J Clin Nutr.
2008;17:280–4.
2. Ikuyama S, Imamura-Takase E, Tokunaga S, Oribe M, Nishimura J. Sixty
percent of patients with rheumatoid arthritis in Japan have used dietary
supplements or health foods. Mod Rheumatol. 2009;19:253–9.
3. Sato Y, Yamagishi A, Hashimoto Y, Virgona N, Hoshiyama Y, Umegaki K. Use
of dietary supplements among preschool children in Japan. J Nutr Sci
Vitaminol (Tokyo). 2009;55:317–25.
4. Wallace RB, Gryzlak BM, Zimmerman MB, Nisly NL. Application of FDA
adverse event report data to the surveillance of dietary botanical
supplements. Ann Pharmacother. 2008;42:653–60.
5. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: a
tabular compilation of reported cases. Liver Int. 2012;32:1543–56.
6. Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C.
Antioxidant supplements for liver diseases. Cochrane Database Syst Rev.
2011;16:CD007749.
7. Pilkington K, Boshnakova A. Complementary medicine and safety: a
systematic investigation of design and reporting of systematic reviews.
Complement Ther Med. 2012;20:73–82.
8. Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R. Patient use of dietary
supplements: a clinician’s perspective. Curr Med Res Opin. 2008;24:1209–16.
9. Morris CA, Avorn J. Internet marketing of herbal products. JAMA.
2003;290:1505–9.
10. Cohen PA. American roulette–contaminated dietary supplements. N Engl J
Med. 2009;361:1523–5.
11. Cohen PA, Venhuis BJ. Adulterated sexual enhancement supplements: more
than mojo. JAMA Intern Med. 2013;173:1169–70.
12. Picciano MF, Dwyer JT, Radimer KL, Wilson DH, Fisher KD, Thomas PR, Yetley
EA, Moshfegh AJ, Levy PS, Nielsen SJ, Marriott BM. Dietary supplement use
among infants, children, and adolescents in the United States, 1999–2002.
Arch Pediatr Adolesc Med. 2007;161:978–85.
13. Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB,
Mozersky RP, Budnitz DS. Emergency department visits for adverse events
related to dietary supplements. N Engl J Med. 2015;373:1531–40.
14. Pitkala KH, Suominen MH, Bell JS, Strandberg TE. Herbal medications and
other dietary supplements. A clinical review for physicians caring for older
people. Ann Med. 2016;48:586–602.
Chiba et al. Nutrition Journal  (2017) 16:18 Page 7 of 8
15. Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V. Hyperforin
in St. John’s wort drug interactions. Eur J Clin Pharmacol. 2006;62:225–33.
16. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed
drugs: an updated systematic review. Drugs. 2009;69:1777–98.
17. Shord SS, Shah K, Lukose A. Drug-botanical interactions: a review of the
laboratory, animal, and human data for 8 common botanicals. Integr Cancer
Ther. 2009;8:208–27.
18. Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators
of pharmacokinetic drug interactions. Planta Med. 2012;78:1458–77.
19. Yokotani K, Chiba T, Sato Y, Taki Y, Yamada S, Shinozuka K, Murata M,
Umegaki K. Hepatic cytochrome P450 mediates interaction between
warfarin and Coleus forskohlii extract in vivo and in vitro. J Pharm
Pharmacol. 2012;64:1793–801.
20. Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins
of metabolic activation of procarcinogens by human cytochrome P450.
Mutat Res. 2001;479:197–206.
21. Bamba Y, Yun YS, Kunugi A, Inoue H. Compounds isolated from Curcuma
aromatica Salisb. inhibit human P450 enzymes. J Nat Med. 2011;65:583–7.
22. Chiba T, Sato Y, Nakanishi T, Yokotani K, Suzuki S, Umegaki K. Inappropriate
usage of dietary supplements in patients by miscommunication with
physicians in Japan. Nutrients. 2014;6:5392–404.
23. Chiba T, Sato Y, Suzuki S, Umegaki K. Concomitant use of dietary
supplements and medicines in patients due to miscommunication with
physicians in Japan. Nutrients. 2015;7:2947–60.
24. Wallace TC. Twenty years of the dietary supplement health and education
act–How should dietary supplements be regulated? J Nutr.
2015;145:1683–6.
25. Young AL, Bass IS. The dietary supplement health and education act. Food
Drug Law J. 1995;50:285–92.
26. Umegaki K, Yamada H, Chiba T, Nakanishi T, Sato Y, Fukuyama S.
Information sources for causality assessment of health problems related to
health foods and their usefulness. Shokuhin Eiseigaku Zasshi. 2013;54:282–9.
27. Gardiner P, Sarma DN, Low Dog T, Barrett ML, Chavez ML, Ko R, Mahady GB,
Marles RJ, Pellicore LS, Giancaspro GI. The state of dietary supplement
adverse event reporting in the United States. Pharmacoepidemiol Drug Saf.
2008;17:962–70.
28. Ashar BH, Rice TN, Sisson SD. Physicians’ understanding of the regulation of
dietary supplements. Arch Intern Med. 2007;167:966–9.
29. Cellini M, Attipoe S, Seales P, Gray R, Ward A, Stephens M, Deuster PA.
Dietary supplements: physician knowledge and adverse event reporting.
Med Sci Sports Exerc. 2013;45:23–8.
30. Tarn DM, Paterniti DA, Good JS, Coulter ID, Galliher JM, Kravitz RL,
Karlamangla AS, Wenger NS. Physician-patient communication about dietary
supplements. Patient Educ Couns. 2013;91:287–94.
31. Wold RS, Lopez ST, Yau CL, Butler LM, Pareo-Tubbeh SL, Waters DL, Garry PJ,
Baumgartner RN. Increasing trends in elderly persons’ use of nonvitamin,
nonmineral dietary supplements and concurrent use of medications. J Am
Diet Assoc. 2005;105:54–63.
32. Tallia AF, Cardone DA. Asthma exacerbation associated with glucosamine-
chondroitin supplement. J Am Board Fam Pract. 2002;15:481–4.
33. Hayashi F, Takimoto H, Yoshita K, Yoshiike N. Perceived body size and desire
for thinness of young Japanese women: a population-based survey. Br J
Nutr. 2006;96:1154–62.
34. Bortolotti M, Coccia G, Grossi G, Miglioli M. The treatment of functional
dyspepsia with red pepper. Aliment Pharmacol Ther. 2002;16:1075–82.
35. Langmead L, Rampton DS. Review article: herbal treatment in
gastrointestinal and liver disease–benefits and dangers. Aliment Pharmacol
Ther. 2001;15:1239–52.
36. Sivarajah V, Abdul Q, Pardoe H, Lunniss P. Ulcerative colitis associated with the
herbal weight loss supplement Hydroxycut. BMJ Case Rep. 2013;2013:1-3.
37. Haller C, Kearney T, Bent S, Ko R, Benowitz N, Olson K. Dietary supplement
adverse events: report of a one-year poison center surveillance project. J
Med Toxicol. 2008;4:84–92.
38. Saldanha LG, Dwyer JT, Andrews KW, Bailey RL, Gahche JJ, Hardy CJ, Holden
JM, Picciano MF, Roseland JM, Thomas PR, Wolf WR: Online dietary
supplement resources. J Am Diet Assoc. 2010;110:1426, 1428, 1430–1.
39. Ide K, Yamada H, Kitagawa M, Kawasaki Y, Buno Y, Matsushita K, Kaji M,
Fujimoto K, Waki M, Nakashima M, Umegaki K. Methods for estimating
causal relationships of adverse events with dietary supplements. BMJ Open.
2015;5:e009038.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Chiba et al. Nutrition Journal  (2017) 16:18 Page 8 of 8
